Paradoxical effects of dupilumab in allergic bronchopulmonary aspergillosis: Resolution of mucus plugging but induction of eosinophilic pneumonia
- PMID: 40499647
- DOI: 10.1016/j.anai.2025.06.006
Paradoxical effects of dupilumab in allergic bronchopulmonary aspergillosis: Resolution of mucus plugging but induction of eosinophilic pneumonia
Conflict of interest statement
Disclosures Dr Matsuno has received lecture fees from GlaxoSmithKline, AstraZeneca, Novartis Pharma, and Sanofi. The remaining authors have no conflicts of interest to report.
LinkOut - more resources
Full Text Sources
